SE9003665D0 - Morphine prodrugs - Google Patents

Morphine prodrugs

Info

Publication number
SE9003665D0
SE9003665D0 SE9003665A SE9003665A SE9003665D0 SE 9003665 D0 SE9003665 D0 SE 9003665D0 SE 9003665 A SE9003665 A SE 9003665A SE 9003665 A SE9003665 A SE 9003665A SE 9003665 D0 SE9003665 D0 SE 9003665D0
Authority
SE
Sweden
Prior art keywords
pct
morphine
date
sec
prodrugs
Prior art date
Application number
SE9003665A
Other languages
English (en)
Swedish (sv)
Inventor
H Bundgaard
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9003665A priority Critical patent/SE9003665D0/xx
Publication of SE9003665D0 publication Critical patent/SE9003665D0/xx
Priority to IE368291A priority patent/IE913682A1/en
Priority to ZA918512A priority patent/ZA918512B/xx
Priority to NZ240349A priority patent/NZ240349A/en
Priority to IL9990591A priority patent/IL99905A/en
Priority to DE69129861T priority patent/DE69129861T2/de
Priority to ES91920399T priority patent/ES2121793T3/es
Priority to AU89381/91A priority patent/AU655612B2/en
Priority to JP50056892A priority patent/JP3493434B2/ja
Priority to CA002095223A priority patent/CA2095223C/fr
Priority to US08/050,336 priority patent/US5908846A/en
Priority to PCT/SE1991/000760 priority patent/WO1992008459A1/fr
Priority to DK91920399T priority patent/DK0557385T3/da
Priority to AT91920399T priority patent/ATE168560T1/de
Priority to EP91920399A priority patent/EP0557385B1/fr
Priority to PT99513A priority patent/PT99513B/pt
Priority to NO931766A priority patent/NO931766D0/no
Priority to FI932212A priority patent/FI932212A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9003665A 1990-11-16 1990-11-16 Morphine prodrugs SE9003665D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9003665A SE9003665D0 (sv) 1990-11-16 1990-11-16 Morphine prodrugs
IE368291A IE913682A1 (en) 1990-11-16 1991-10-21 Morphine prodrugs
ZA918512A ZA918512B (en) 1990-11-16 1991-10-25 Morphine prodrugs
NZ240349A NZ240349A (en) 1990-11-16 1991-10-25 Topical compositions for transdermal delivery of morphine prodrugs
IL9990591A IL99905A (en) 1990-11-16 1991-10-30 Topical compositions for transdermal delivery of morphine prodrugs
EP91920399A EP0557385B1 (fr) 1990-11-16 1991-11-11 Compositions a administration locale destinees a l'asministration transdermique de derives de promedicament de morphine
JP50056892A JP3493434B2 (ja) 1990-11-16 1991-11-11 モルヒネのプロドラッグ誘導体の経皮供給用の局所組成物
ES91920399T ES2121793T3 (es) 1990-11-16 1991-11-11 Composiciones de uso local para la administracion transdermica de derivados profarmacos de morfina.
AU89381/91A AU655612B2 (en) 1990-11-16 1991-11-11 Topical compositions for transdermal delivery of produg derivatives of morphine
DE69129861T DE69129861T2 (de) 1990-11-16 1991-11-11 Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
CA002095223A CA2095223C (fr) 1990-11-16 1991-11-11 Compositions topiques pour l'administration transdermique de derives de precurseurs de morphine
US08/050,336 US5908846A (en) 1990-11-16 1991-11-11 Topical compositions for transdermal delivery of prodrug derivatives of morphine
PCT/SE1991/000760 WO1992008459A1 (fr) 1990-11-16 1991-11-11 Compositions a administration locale destinees a l'asministration transdermique de derives de promedicament de morphine
DK91920399T DK0557385T3 (da) 1990-11-16 1991-11-11 Topiske sammensætninger til transdermal afgivelse af prodrug-derivater af morfin
AT91920399T ATE168560T1 (de) 1990-11-16 1991-11-11 Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
PT99513A PT99513B (pt) 1990-11-16 1991-11-14 Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
NO931766A NO931766D0 (no) 1990-11-16 1993-05-14 Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
FI932212A FI932212A (fi) 1990-11-16 1993-05-14 Topikal kompositioner foer transdermal transmission av morfinets prodrugderivat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003665A SE9003665D0 (sv) 1990-11-16 1990-11-16 Morphine prodrugs

Publications (1)

Publication Number Publication Date
SE9003665D0 true SE9003665D0 (sv) 1990-11-16

Family

ID=20380936

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003665A SE9003665D0 (sv) 1990-11-16 1990-11-16 Morphine prodrugs

Country Status (18)

Country Link
US (1) US5908846A (fr)
EP (1) EP0557385B1 (fr)
JP (1) JP3493434B2 (fr)
AT (1) ATE168560T1 (fr)
AU (1) AU655612B2 (fr)
CA (1) CA2095223C (fr)
DE (1) DE69129861T2 (fr)
DK (1) DK0557385T3 (fr)
ES (1) ES2121793T3 (fr)
FI (1) FI932212A (fr)
IE (1) IE913682A1 (fr)
IL (1) IL99905A (fr)
NO (1) NO931766D0 (fr)
NZ (1) NZ240349A (fr)
PT (1) PT99513B (fr)
SE (1) SE9003665D0 (fr)
WO (1) WO1992008459A1 (fr)
ZA (1) ZA918512B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
JPH07267862A (ja) * 1994-03-29 1995-10-17 Sekisui Chem Co Ltd 経皮吸収貼付剤
WO1996028451A1 (fr) * 1995-03-14 1996-09-19 Euroceltique S.A. Morphine-3-esters
DE19508664C2 (de) * 1995-03-14 2001-08-23 Christian Mignat Verwendung von Morphin-3-estern, Morphin-3-ester als solche und Verfahren zu deren Herstellung
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
DE19602963A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
US6569449B1 (en) * 2000-11-13 2003-05-27 University Of Kentucky Research Foundation Transdermal delivery of opioid antagonist prodrugs
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
KR100612398B1 (ko) * 2000-11-14 2006-08-16 바이탈 헬스 사이언시즈 피티와이 리미티드 포스페이트 유도체의 착체
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
CN1547475B (zh) * 2001-07-27 2010-12-15 生命健康科学有限公司 含电子转移试剂的磷酸酯衍生物的皮肤制剂
CN1604772A (zh) * 2001-12-13 2005-04-06 生命健康科学有限公司 化合物的透皮转运
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
ATE444296T1 (de) * 2002-10-25 2009-10-15 Euro Celtique Sa Analoga und prodrugs von buprenorphin
WO2004043396A2 (fr) * 2002-11-09 2004-05-27 Nobex Corporation Promedicaments contenant du carbamate modifie et methodes de synthese de ces derniers
MXPA05007278A (es) * 2003-01-17 2005-09-30 Vital Health Sciences Pty Ltd Compuestos que tienen propiedades anti-proliferativas.
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
CA2529983C (fr) * 2003-07-25 2010-07-20 Bruce E. Reidenberg Traitement preoperatoire de la douleur postoperatoire
KR100921695B1 (ko) * 2004-02-06 2009-10-15 유로-셀띠끄 소시에떼 아노님 3-ｏ-보호된 모르피논 및 3-ｏ-보호된 모르피논 디엔올카르복실레이트 제조방법
LT2351555T (lt) 2004-02-23 2016-12-27 Euro-Celtique S.A. Piktnaudžiavimui atspari priemonė, skirta transderminiam opoido įvedimui
JP4847437B2 (ja) 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
RU2008123556A (ru) * 2005-12-23 2010-01-27 Вайтал Хэлф Сайнсис Пти Лтд (Au) Составы, имеющие цитокин модулирующие свойства
RU2428186C2 (ru) 2007-03-02 2011-09-10 Теика Фармасьютикал Ко., Лтд. Лекарственная композиция для чрескожной абсорбции, изделие, сохраняющее лекарственную композицию, и содержащий ее препарат для чрескожной абсорбции
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
US8784872B2 (en) 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
US20100104614A1 (en) * 2008-06-27 2010-04-29 Oronsky Bryan T Providone compositions for wound healing
AU2010266209B2 (en) * 2009-07-02 2013-09-26 Kempharm, Inc. Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
UA102916C2 (uk) 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
US10849981B2 (en) 2009-07-02 2020-12-01 KemPham, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
RU2553350C2 (ru) 2010-03-30 2015-06-10 Фосфейдженикс Лимитед Трансдермальные пластыри
CA2796575C (fr) 2010-04-13 2018-05-15 Relmada Therapeutics, Inc. Compositions pharmaceutiques dermiques de 1-methyl-2',6'-pipecoloxylidide et methode d'utilisation
TWI520732B (zh) 2011-01-18 2016-02-11 輝瑞有限公司 固體分子分散液
WO2012122586A1 (fr) 2011-03-15 2012-09-20 Phosphagenics Limited Nouvelle composition
NZ731591A (en) 2014-11-25 2018-06-29 Kempharm Inc Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
EP3383371B1 (fr) 2015-12-09 2024-05-01 Avecho Biotechnology Limited Formulation pharmaceutique
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US4891377A (en) * 1988-12-02 1990-01-02 Board Of Regents Acting For And On Behalf Of University Of Michigan Transdermal delivery of the narcotic analgesics etorphine and analogs
DE69122464T2 (de) * 1990-03-30 1997-02-20 Yasunori Morimoto Transdermal absorbierbares mittel mit morphin hydrochlorid
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine

Also Published As

Publication number Publication date
IL99905A0 (en) 1992-08-18
ZA918512B (en) 1992-08-26
CA2095223A1 (fr) 1992-05-17
CA2095223C (fr) 2002-12-17
AU655612B2 (en) 1995-01-05
NO931766L (no) 1993-05-14
DE69129861T2 (de) 1999-04-01
FI932212A0 (fi) 1993-05-14
NZ240349A (en) 1993-07-27
EP0557385B1 (fr) 1998-07-22
ATE168560T1 (de) 1998-08-15
EP0557385A1 (fr) 1993-09-01
WO1992008459A1 (fr) 1992-05-29
NO931766D0 (no) 1993-05-14
IL99905A (en) 1995-06-29
PT99513B (pt) 1999-04-30
PT99513A (pt) 1992-09-30
JP3493434B2 (ja) 2004-02-03
IE913682A1 (en) 1992-05-20
JPH06502422A (ja) 1994-03-17
FI932212A (fi) 1993-05-14
DE69129861D1 (de) 1998-08-27
DK0557385T3 (da) 1999-04-26
ES2121793T3 (es) 1998-12-16
US5908846A (en) 1999-06-01
AU8938191A (en) 1992-06-11

Similar Documents

Publication Publication Date Title
SE9003665D0 (sv) Morphine prodrugs
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
GB9319695D0 (en) Substituted-2-phenyl-3-methoxypropenoates as fungicides
FI954963A0 (fi) Poly-1-n-alkeeniamiineja ja näitä sisältäviä poltto- ja voiteluainekoostumuksia
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
MX9203319A (es) Metodo para la preparacion de cristales de alfa-2 interferona.
MY106109A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
TR199900951T2 (xx) G���s kanserinin engellenmesi i�in y�ntemler.
ATE231131T1 (de) Verbindungen mit wachtumshormon freisetzenden eigenschaften
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
DE69727385D1 (de) Benzophenanthridinalkaloid-enthaltende pestizide
DE59000613D1 (de) Pflaster zur transdermalen anwendung.
DE69426021D1 (de) Xamonelin-Tartrat
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
ES2097816T5 (es) Producto y su uso para el tratamiento de estados catabolicos que comprende ifg-1 autentico y cantidades hipocaloricas de nutrientes.
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
IL100765A0 (en) Vaccine composition against influenza,with synergic effects containing influenza virus core as an additive
DK0599894T3 (da) Anvendelse af aminoalkanolamidestere som hjælpemidler ved forarbejdning af termoplastiske formstoffer
MY108690A (en) Mildewproofing agent for timber
ES2158089T3 (es) Uso de derivados de fosforo de alcaloides para el tratamiento de endocrinopatias.
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)